Srishti Khurana

The number and geographical distribution of clinical trials are important indicators of both the therapeutic viability and future potential of innovative pharmacological interventions. These trials...

Outsourcing provides a platform for establishing strategic collaborations, which eventually helps players to augment their expertise in this domain, through access to lucrative and innovative cost...

The annual, global demand for therapeutic peptide APIs is estimated to be 2,145 kg in 2020, and this value is projected to reach about 3,800 kg by 2025, growing at a CAGR of 10%. Given that majority...

Several industry players have established peptide manufacturing facilities across the world. During our research, we came across North America and Europe emerged as the current manufacturing hub for...

During our research, we came across several partnerships and collaborations that have been inked, during the period 2014-2019, between various stakeholders involved in the peptide therapeutics...

Given the growing preference for outsourcing in the pharmaceutical industry, it is imperative for stakeholders to be able to draw a distinction between making a product (insourcing) or buying it from...

Over the years, the peptide therapeutics domain has evolved significantly. In fact, till date, more than 60 peptide therapeutics have been approved across different parts of the globe. However, the...

Prefilled syringes were first launched in the 1970s and since then have undergone considerable changes. As such products continue to evolve each year, regulations and laws governing the various...

The demand for prefilled syringes has increased rapidly over the past several years, driven by the advantages offered over traditional drug delivery methods. As a result, the adoption of this mode of...

The prefilled syringes available in the market have undergone various technological advancements in features. In the recent years, manufacturers have developed several prefilled syringes that are...

The key parameters that, we believe, are likely to have an influence on the regional capability of biopharmaceutical manufacturing, and hence, were taken into consideration, include:Number of CMOs...

Technical advances and innovation in design within the medical devices industry have prompted regulatory authorities to update the laws governing various aspects of the development, manufacturing...

In the recent past, several companies have collaborated with other industry players / research institutes to develop novel RNAi based products. According to our research, most of the deals inked in...

In 2019, the projected market is worth USD 160 million. We expect the overall RNAi therapeutics market to be worth USD 3.9 billion by 2025 and this value is projected to reach USD 9.2 billion by 2030...

Brand positioning analysis of the key industry players helps to develop an understanding on how the brands of companies are currently perceived / positioned in different market segments relative to...